Alberico Luigi Catapano

Full Professor

University of Milan

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (19)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (13)

Manuela Casula

University of Milan

ITALY

View details

Wolfgang Koenig

Universität Ulm

GERMANY

View details

jan cornel

Professor

Radboud University Medical Center

NETHERLANDS

View details

Erik S G Stroes

Amsterdam University Medical Centers

NETHERLANDS

View details

Manuel Mayr

Prof of Cardiovascular Proteomics

Imperial College London

UNITED KINGDOM

View details

Carmine Izzo

Professor

Università degli Studi di Napoli Federico II

ITALY

View details

Nick S Nurmohamed

University of Amsterdam

NETHERLANDS

View details

Patrizia Tarugi

Full Professor of General Pathology

Università degli Studi di Modena e Reggio Emilia - Sede di Reggio Emilia

ITALY

View details

G. Kees Hovingh

NETHERLANDS

View details

Paolo Calabrò

University of Campania “Luigi Vanvitelli”

ITALY

View details

Arnold von Eckardstein

chairman of the institute/ professor

University of Zurich

SWITZERLAND

View details

Anna Solini

ITALY

View details

Kausik Ray

Professor of Public Health

Imperial College London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Alberico Luigi Catapano

Research Interests

Explore related searches

Contact this professor

Articles (19)

The LDL cumulative exposure hypothesis: evidence and practical applications

In memoriam: Akira Endo

Disconnect between triglyceride reduction and cardiovascular outcomes: lessons from the PROMINENT and CLEAR Outcomes trials

Proprotein convertase subtilisisn/kexin type 9 inhibitors: the earlier the better?

European Lipid Guidelines and Cardiovascular Risk Estimation: Current Status and Future Challenges

Effect of anti-PCSK9 drugs on the association of PCSK9 to LDL

Effect of lipid-lowering therapies on C-reactive protein levels: a comprehensive meta-analysis of randomized controlled trials

Efficacy and safety of bempedoic acid in patients with heterozygous familial hypercholesterolemia: analysis of pooled patient-level data from phase 3 clinical trials

Exploring apolipoprotein C-III: pathophysiological and pharmacological relevance

Effect of PCSK9 Inhibition on the Plasma Proteome: A SPIRE SubStudy

Glycerol and β-hydroxybutyrate: friends or foes?

Cardiovascular risk assessment: are we getting all the information we need?

Cholesterol Lowering Biotechnological Strategies: From Monoclonal Antibodies to Antisense Therapies. A Pre-Clinical Perspective Review

Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia

Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction

Lipid-lowering treatment and LDL-C goal attainment in high and very high cardiovascular risk patients: Evidence from the SANTORINI study-The Italian experience

High-density lipoprotein revisited: biological functions and clinical relevance

The XVI National Congress of the Società Italiana di Terapia Clinica e Sperimentale (SITeCS): Conference report

Remnant cholesterol: a reliable prognostic marker?

Collaborators (13)

Manuela Casula

Wolfgang Koenig

jan cornel

Erik S G Stroes

Manuel Mayr

Carmine Izzo

Nick S Nurmohamed

Patrizia Tarugi

G. Kees Hovingh

Paolo Calabrò

Arnold von Eckardstein

Anna Solini

Kausik Ray

Make your next move.